| BUISX | NRGSX | BUISX / NRGSX | |
| Total Expense Ratio | 0.87 | 0.74 | 118% |
| Annual Report Gross Expense Ratio | 0.87 | 0.74 | 118% |
| Fund Existence | 7 years | 13 years | - |
| Gain YTD | 4.539 | 5.452 | 83% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 446M | 8.49B | 5% |
| Annual Yield % from dividends | 0.00 | 0.48 | - |
| Returns for 1 year | 1.69 | -12.75 | -13% |
| Returns for 3 years | 3.43 | -6.33 | -54% |
| Returns for 5 years | -33.59 | -23.10 | 145% |
| Returns for 10 years | N/A | 24.83 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DNEMX | 19.53 | 0.27 | +1.40% |
| Dunham Emerging Markets Stock N | |||
| TBWAX | 22.57 | 0.12 | +0.53% |
| Thornburg Better World International A | |||
| FPHAX | 31.97 | N/A | N/A |
| Fidelity Select Pharmaceuticals Port | |||
| LAMHX | 26.20 | -0.08 | -0.30% |
| Lord Abbett Dividend Growth R6 | |||
| RAMHX | 38.17 | -0.16 | -0.42% |
| American Funds American Balanced R2E | |||